Increasing ketamine administration in children's hospitals for youth with sickle cell disease

Research
Written By Christine Briscoe

Authors: Ashley Jenkins, Erin Hendry, Alexandra Power-Hays, Marin Valentino, Matthew Hall, Kathryn E. Kyler, James W Antoon, Sonya Tang Girdwood, Jennifer Goldman, Armand Morel, Timothy Savage, Lucas Orth, and Natasha M. Archer

Published: December 3, 2025

Click Here to Read More
Christine Briscoe
Previous

Motivators and barriers affecting decisions to participate in sickle cell disease clinical trials in the global Learning and Insights into Sickle Cell Trial Experiences Survey
Next

Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US